Study of SX-682 Plus Enzalutamide in Men With ARPI-Resistant Metastatic Castration Resistant Prostate Cancer
Clinical trial NCT06228053 · RECRUITING
Trial details
- NCT number
- NCT06228053
- Sponsor
- Syntrix Biosystems, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-18
- Primary completion
- 2027-06-30
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.